Stocktoria
STERIS plc STE
STERIS plc (STE) earns a Piotroski F-score of 9/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.15% (safety: safe). FY2026 revenue was $5.9B at a 13.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.68 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-07 | UBS | Buy (main) |
| 2026-08-07 | Piper Sandler | Overweight (reit) |
| 2026-07-28 | UBS | Buy (init) |
| 2026-05-13 | Keybanc | Overweight (main) |
| 2025-08-08 | Morgan Stanley | Overweight (main) |
| 2025-07-22 | Keybanc | Overweight (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 9/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.116 |
| Retained earnings / assets | 0.281 |
| EBIT / assets | 0.103 |
| Equity / liabilities | 2.033 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| STE | STERIS plc | 9/9 | 4.5 | 26.9 | +8.7% |
| EW | Edwards Lifesciences Corp | 6/9 | 9.6 | 48.7 | +11.5% |
| ALGN | ALIGN TECHNOLOGY INC | 6/9 | 4.56 | 31.1 | +0.9% |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | 5/9 | 3.96 | 24.5 | +7.2% |
| ENOV | Enovis CORP | 4/9 | -1.51 | — | +6.7% |
| MSA | MSA Safety Inc | 6/9 | 5.65 | 23.6 | +3.7% |
| ISRG | INTUITIVE SURGICAL INC | 6/9 | 12.06 | 50.2 | +20.5% |
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
FAQ
Is STE financially healthy?
STERIS plc's Piotroski F-score is 9/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does STE pay a dividend, and is it safe?
Yes. STERIS plc pays a dividend yielding about 1.15% with a 30.9% payout ratio, rated “safe” for safety.
How profitable is STE?
In FY2026, STERIS plc had a net margin of 13.2% and a return on equity of 10.9%.
Is STE overvalued or undervalued?
STERIS plc trades at about 29.8× trailing earnings — below its 10-year norm (10-year range 27.3×–176.2×, median 36.9×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for STE?
The average Wall-Street price target for STERIS plc is $263.12, about 11.2% above the recent price, from 8 analysts (consensus: buy).
Is STE a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on STERIS plc: a Piotroski F-score of 9/9, an Altman Z″ in the safe zone, a P/E of about 26.9×, a dividend yield of 1.15%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.